{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:23:55Z","timestamp":1649193835652},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00108-021-01196-6","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T17:03:51Z","timestamp":1635440631000},"page":"1364-1366","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transglutaminase-2-Inhibitor zur Therapie der Z\u00f6liakie"],"prefix":"10.1007","volume":"62","author":[{"given":"Christopher","family":"Dietz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nitschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"issue":"12","key":"1196_CR1","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1055\/s-0043-120347","volume":"55","author":"O Lei\u00df","year":"2017","unstructured":"Lei\u00df\u00a0O (2017) Gluten-free diet\u2014Update 2017. Z\u00a0Gastroenterol 55(12):1323\u20131343","journal-title":"Z Gastroenterol"},{"issue":"7","key":"1196_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nm0797-797","volume":"3","author":"W Dieterich","year":"1997","unstructured":"Dieterich\u00a0W et\u00a0al (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3(7):797\u2013801","journal-title":"Nat Med"},{"issue":"5","key":"1196_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1053\/j.gastro.2021.08.016","volume":"161","author":"EF Verdu","year":"2021","unstructured":"Verdu\u00a0EF, Schuppan\u00a0D (2021) Co-factors, microbes, and immunogenetics in celiac disease to guide novel approaches for diagnosis and treatment. Gastroenterology 161(5):1395\u20131411.e4","journal-title":"Gastroenterology"},{"issue":"1","key":"1196_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00394-015-1062-3","volume":"56","author":"C Hoppe","year":"2017","unstructured":"Hoppe\u00a0C et al (2017) Intake and sources of gluten in 20- to 75-year-old Danish adults: a\u00a0national dietary survey. Eur J Nutr 56(1):107\u2013117","journal-title":"Eur J Nutr"},{"issue":"12","key":"1196_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1080\/00365521.2016.1218540","volume":"51","author":"P H\u00e6re","year":"2016","unstructured":"H\u00e6re\u00a0P et al (2016) Long-term mucosal recovery and healing in celiac disease is the rule\u2014not the exception. Scand J Gastroenterol 51(12):1439\u20131446","journal-title":"Scand J Gastroenterol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01196-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T12:04:54Z","timestamp":1638965094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1196"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01196-6","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"29 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H. Wedemeyer erhielt F\u00f6rdermittel von Falk Pharma f\u00fcr die Durchf\u00fchrung von Studien sowie als Vortrags- und Beratungshonorar. C.\u00a0Dietz und S.\u00a0Nitschmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}